Prognostic utility of TME-associated genes in pancreatic cancer

Prognostic utility of TME-associated genes in pancreatic cancer

Background: Pancreatic cancer (PC) is a deadly disease. The tumor microenvironment (TME) participates in PC oncogenesis. This study focuses on the assessment of the prognostic and treatment utility of TME-associated genes in PC.Methods: After obtaining the differentially expressed TME-related genes,...

Full description

Bibliographic Details
Main Authors:	Yuanhua Nie, Longwen Xu, Zilong Bai, Yaoyao Liu, Shilong Wang, Qingnuo Zeng, Xuan Gao, Xuefeng Xia, Dongmin Chang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-09-01
Series:	Frontiers in Genetics
Subjects:	pancreatic cancer tumor microenvironment prognostic risk model immunotherapy therapeutic target
Online Access:	https://www.frontiersin.org/articles/10.3389/fgene.2023.1218774/full

Similar Items

Analysis of M2 macrophage-associated risk score signature in pancreatic cancer TME landscape and immunotherapy
by: Dashuai Yang, et al.
Published: (2023-07-01)

Construction and validation of a RARRES3-based prognostic signature related to the specific immune microenvironment of pancreatic cancer
by: Yimeng Sun, et al.
Published: (2024-02-01)

Prognostic Value and Correlation With Tumor Immune Infiltration of a Novel Metabolism-Related Gene Signature in Pancreatic Cancer
by: Hui Chen, et al.
Published: (2022-01-01)

A pyroptosis-related gene signature for prognosis and immune microenvironment of pancreatic cancer
by: Sifan Tao, et al.
Published: (2022-08-01)

Exploitation and Verification of a Stroma- and Metastasis-Associated Risk Prognostic Signature in Pancreatic Adenocarcinoma
by: Jia-Hao Zheng, et al.
Published: (2022-10-01)

Platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with gastric cancer undergoing radical resection
by: Qingnuo Zeng, et al.
Published: (2024-03-01)

Development and validation of cuproptosis-related lncRNAs associated with pancreatic cancer immune microenvironment based on single-cell
by: Yimeng Sun, et al.
Published: (2023-09-01)

Identification of a chemoresistance-related prognostic gene signature by comprehensive analysis and experimental validation in pancreatic cancer
by: Junliang Chen, et al.
Published: (2023-05-01)

CXCL10 is a prognostic marker for pancreatic adenocarcinoma and tumor microenvironment remodeling
by: Yuan Nie, et al.
Published: (2023-02-01)

Identification of tumour immune microenvironment-related alternative splicing events for the prognostication of pancreatic adenocarcinoma
by: Bo Chen, et al.
Published: (2021-11-01)

Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy
by: Xinlei Zou, et al.
Published: (2023-07-01)

PCDH1, a poor prognostic biomarker and potential target for pancreatic adenocarcinoma metastatic therapy
by: Xingyi Du, et al.
Published: (2023-11-01)

A prognostic mathematical model based on tumor microenvironment-related genes expression for breast cancer patients
by: Hong Chen, et al.
Published: (2023-10-01)

Identification of gene signatures related to hypoxia and angiogenesis in pancreatic cancer to aid immunotherapy and prognosis
by: Xiushen Li, et al.
Published: (2023-03-01)

Genomic and immunogenomic analysis of three prognostic signature genes in LUAD
by: Hai-Ming Feng, et al.
Published: (2023-01-01)

Immune Checkpoint Neuropilins as Novel Biomarkers and Therapeutic Targets for Pancreatic Cancer
by: Li-Hong He, et al.
Published: (2023-04-01)

An Automated Prognostic Model for Pancreatic Ductal Adenocarcinoma
by: Ioannis Vezakis, et al.
Published: (2023-08-01)

PANoptosis-related molecular subtype and prognostic model associated with the immune microenvironment and individualized therapy in pancreatic cancer
by: Biao Zhang, et al.
Published: (2023-07-01)

The Next Frontier in Pancreatic Cancer: Targeting the Tumor Immune Milieu and Molecular Pathways
by: Chao Yin, et al.
Published: (2022-05-01)

An Immunological Glance on Pancreatic Ductal Adenocarcinoma
by: Michael Karl Melzer, et al.
Published: (2020-05-01)

Decreased Activity of Circulating Butyrylcholinesterase in Blood Is an Independent Prognostic Marker in Pancreatic Cancer Patients
by: Eva Valentina Klocker, et al.
Published: (2020-05-01)

Prognostic and Therapeutic Role of Angiogenic Microenvironment in Thyroid Cancer
by: Assunta Melaccio, et al.
Published: (2021-06-01)

A Comparison of Spatial and Phenotypic Immune Profiles of Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions
by: Thomas Enzler, et al.
Published: (2024-03-01)

High ANO1 expression is a prognostic factor and correlated with an immunosuppressive tumor microenvironment in pancreatic cancer
by: Guangnian Zhang, et al.
Published: (2024-01-01)

CHST12: a potential prognostic biomarker related to the immunotherapy response in pancreatic adenocarcinoma
by: Kun Liu, et al.
Published: (2024-01-01)

Diagnostic, Predictive and Prognostic Molecular Biomarkers in Pancreatic Cancer: An Overview for Clinicians
by: Dimitrios Giannis, et al.
Published: (2021-03-01)

The Potential Role of the T2 Ribonucleases in TME-Based Cancer Therapy
by: Paola Campomenosi, et al.
Published: (2023-08-01)

Exploring the Potential of Pyroptosis-Related Genes in Predicting Prognosis and Immunological Characteristics of Pancreatic Cancer From the Perspective of Genome and Transcriptome
by: Jing Zhang, et al.
Published: (2022-06-01)

Nanoparticle-based immunotherapy of pancreatic cancer
by: Gaetan Aime Noubissi Nzeteu, et al.
Published: (2022-08-01)

Latest Advances in the Use of Therapeutic Focused Ultrasound in the Treatment of Pancreatic Cancer
by: Petros X. E. Mouratidis, et al.
Published: (2022-01-01)

Discovering a Four-Gene Prognostic Model Based on Single-Cell Data and Gene Expression Data of Pancreatic Adenocarcinoma
by: Weizhen Huang, et al.
Published: (2022-06-01)

Identification of a tissue resident memory CD8 T cell-related risk score signature for colorectal cancer, the association with TME landscapes and therapeutic responses
by: Jiazheng Li, et al.
Published: (2023-01-01)

Targeting tumor immunosuppressive microenvironment for pancreatic cancer immunotherapy: Current research and future perspective
by: Ying Li, et al.
Published: (2023-03-01)

Exploring the Biology of Cancer-Associated Fibroblasts in Pancreatic Cancer
by: Adam S. Bryce, et al.
Published: (2022-10-01)

A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma
by: Yusheng Chen, et al.
Published: (2023-04-01)

Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma
by: Jian Li, et al.
Published: (2023-01-01)

DLL3 Is a Prognostic and Potentially Predictive Biomarker for Immunotherapy Linked to PD/PD-L Axis and NOTCH1 in Pancreatic Cancer
by: Carlos Lacalle-Gonzalez, et al.
Published: (2023-10-01)

Mitochondrial energy metabolism-related gene signature as a prognostic indicator for pancreatic adenocarcinoma
by: Yu Ma, et al.
Published: (2024-03-01)

Overcoming the Fibrotic Fortress in Pancreatic Ductal Adenocarcinoma: Challenges and Opportunities
by: Kay K. Myo Min, et al.
Published: (2023-04-01)

GBP2 as a potential prognostic biomarker in pancreatic adenocarcinoma
by: Bo Liu, et al.
Published: (2021-05-01)